Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1Genitourinary 1

Conditions

Prostatic Neoplasms 6Erectile Dysfunction 4Urogenital Neoplasms 1Urinary Incontinence 1Sexual Dysfunction, Physiological 1

Interventions

Psychiatric Rehabilitation 3Counseling 3Sildenafil Citrate 2Radiotherapy 2High-Intensity Focused Ultrasound Ablation 2methyl N-acetylsibirosaminide 1methyl 3-mercaptopropionimidate 1bicalutamide 1Tadalafil 1Surveys and Questionnaires 1Restraint, Physical 1Radiosurgery 1Prostatectomy 1Phentolamine 1Papaverine 1Menogaril 1Magnetic Resonance Spectroscopy 1Leuprolide 1Goserelin 1Flutamide 1Finasteride 1Family Characteristics 1Diet Therapy 1Cognitive Behavioral Therapy 1Chemotherapy, Adjuvant 1Biopsy 1Biofeedback, Psychology 1Alprostadil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sexual Dysfunction, Physiological × Tadalafil × Genitourinary × Clear all
NCT00931528 2018-02-14

Tadalafil in Preventing Erectile Dysfunction in Patients With Prostate Cancer Treated With Radiation Therapy

Radiation Therapy Oncology Group

Phase 3 Completed
242 enrolled 13 charts
GenitourinaryOther

Prostatic Neoplasms, Sexual Dysfunction, Physiological

Data powered by HemOnc (CC BY 4.0) Colophon âš¡